Kenichi Kurosaki

Dr. Kenichi Kurosaki

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2014 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
THTakaya Hoashi
Takaya Hoashi
KKKoji Kagisaki
Koji Kagisaki
KKKenichi Kurosaki
Kenichi Kurosaki
MKMasataka Kitano
Masataka Kitano
Isao ShiraishiIsao Shiraishi
Isao Shiraishi
HIHajime Ichikawa
Hajime Ichikawa

1 August 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
YHYohsuke Hayama
Yohsuke Hayama
HOHideo Ohuchi
Hideo Ohuchi
JNJun Negishi
Jun Negishi
TIToru Iwasa
Toru Iwasa
HSHeima Sakaguchi
Heima Sakaguchi
KKKenichi Kurosaki
Kenichi Kurosaki

1 June 2020 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MKMotoki Komori
Motoki Komori
THTakaya Hoashi
Takaya Hoashi
MSMasatoshi Shimada
Masatoshi Shimada
MKMasataka Kitano
Masataka Kitano
HOHideo Ohuchi
Hideo Ohuchi
HIHajime Ichikawa
Hajime Ichikawa

25 November 2020 in Circulation Journal
Verified
Journal Article
Open access
PDF file
KKKenichi Kurosaki
Kenichi Kurosaki
MKMasataka Kitano
Masataka Kitano
HSHeima Sakaguchi
Heima Sakaguchi
ISIsao Shiraishi
Isao Shiraishi
NINaoko Iwanaga
Naoko Iwanaga
SYSatoshi Yasuda
Satoshi Yasuda
Background:Congenital heart disease (CHD) is often diagnosed prenatally using fetal echocardiography, but few studies have evaluated the accuracy of these fetal cardiac diagnoses in detail. We investigated the discrepancy between pre- and postnatal diagnoses of CHD and the impact of discrepant diagnoses. Methods and Results:This retrospective study at a tertiary institution included data from the medical records of 207 neonates with prenatally diagnosed CHD admitted to the cardiac neonatal intensive care unit between January 2011 and December 2016. Pre- and postnatal diagnoses of CHD differed in 12% of neonates. Coarctation of the aorta and ventricular septal defects were the most frequent causes of discrepant diagnosis. Unexpected treatments were added to 38% of discrepant diagnostic cases. However, discrepant diagnoses did not adversely affect the clinical course. The 9% of the 207 neonates who required invasive intervention within 24 h of delivery were accurately diagnosed prenatally. Conclusions:Pre- and postnatal diagnoses differed in only a few neonates, with differences not adversely affecting the clinical course. Neonates who required invasive intervention immediately after delivery were accurately diagnosed prenatally. Prenatal diagnosis thus seems to contribute to improved prognosis in neonates with CHD.

Verified
Journal Article
Open access
PDF file
TIToru Iwasa
Toru Iwasa
AUAkihiro Urasaki
Akihiro Urasaki
YKYuki Kakihana
Yuki Kakihana
NNNami Nagata-Akaho
Nami Nagata-Akaho
YHYukihiro Harada
Yukihiro Harada
ONOsamu NAKAGAWA
Osamu NAKAGAWA
Hereditary hemorrhagic telangiectasia (HHT) is a vascular disease caused by the defects of ALK1/ACVRL1 receptor signaling. In this study, we evaluated 25 recently identified ACVRL1 missense variants using multiple computational pathogenicity classifiers and experimentally characterized their signal transduction capacity. Three extracellular residue variants showed no detectable cell surface expression and impairment of bone morphogenetic protein 9 (BMP9) responsiveness of SMAD-dependent transcription in luciferase assays. Four variants with amino acid replacement in the motifs essential for the intracellular kinase function lost SMAD-dependent signaling. Most of other variations in the kinase domain also caused marked downregulation of signaling; however, two variants behaved as the wild-type ACVRL1 did, while computational classifiers predicted their functional abnormalities. Three-dimensional structure prediction using the ColabFold program supported the significance of the L45 loop and NANDOR domain of ACVRL1 for its association with SMAD1 and BMPR2, respectively, and the variations in these motifs resulted in the reduction of SMAD signaling. On the other hand, two of the GS domain variants maintained high signal transduction capacity, which did not accord with their computational pathogenicity prediction. These results affirm the requirement of a combinatory approach using computational and experimental analyses to accurately predict the pathogenicity of ACVRL1 missense variants in the HHT patients.

18 March 2020 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
TYTakashi Yasukawa
Takashi Yasukawa
THTakaya Hoashi
Takaya Hoashi
MKMasataka Kitano
Masataka Kitano
MSMasatoshi Shimada
Masatoshi Shimada
KIKenta Imai
Kenta Imai
HIHajime Ichikawa
Hajime Ichikawa
OBJECTIVES: Our goal was to assess the efficacy of managing pulmonary blood flow from the Norwood procedure with a right ventricle-to-pulmonary artery (RV–PA) conduit until stage 2 palliation (S2P). METHODS: Among 48 consecutive patients undergoing the Norwood procedure between 2008 and 2018, 40 (83.3%) patients who survived to discharge were included in this study. The primary diagnosis was hypoplastic left heart syndrome in 28 (70%) patients and hypoplastic left heart syndrome variant in 12 (30%) patients. All patients received bilateral pulmonary artery banding. The median age and weight at the time of the Norwood procedure were 41 (25th–75th percentiles: 27–89) days and 3.2 (2.7–3.9) kg, respectively. In keeping with institutional strategy, S2P was undertaken when body weight exceeded 5.0 kg, and normal gross motor development was confirmed. RESULTS: The RV–PA conduit was clipped in 28 (70%) patients during the perioperative period of the Norwood procedure, then partial unclipping was performed in 8 (20%) patients and full unclipping was performed in 20 (50%) patients. Before S2P, the median pulmonary-to-systemic blood flow ratio was 1.0 (0.7–1.3). The median age and weight at the time of S2P were 10.7 (9.0–12.9) months and 6.3 (5.5–7.1) kg, respectively. The survival rate 5 years after Norwood discharge was 85.3%. Pre-S2P pulmonary-to-systemic blood flow ratio was linearly correlated with greater interstage changes in systemic atrioventricular valve regurgitation (R2 = 0.223, P = 0.004). CONCLUSIONS: Interstage management of pulmonary blood flow by RV–PA conduit clipping and gradual unclipping provided good interstage outcomes. The median pulmonary-to-systemic blood flow ratio could be controlled to 1.0 at pre-S2P catheter examination.